This statistic depicts the estimated avoidable healthcare costs due to delayed evidence-based treatment practice in the United States in 2012, by disease. In that year, atrial fibrillation was estimated to create a total of 0.7 billion U.S. dollars in avoidable costs. Total avoidable delayed evidence-based treatment practice healthcare costs reached 39.5 billion U.S. dollars in that year. Expected increase in insurance coverage, chronic diseases, and an aging population may place further stresses on the need for proper medication use to prevent avoidable healthcare costs.
Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*
Profit from additional features by authenticating your Admin account
Please authenticate by going to "My account" → "Administration".
Then you will be able to mark statistics as favourites and use personal statistics alerts.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
IMS Health. (June 28, 2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* [Graph]. In Statista. Retrieved January 26, 2022, from https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*." Chart. June 28, 2013. Statista. Accessed January 26, 2022. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. (2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: January 26, 2022. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable Healthcare Costs Due to Delayed Treatment Practice in The U.S. in 2012, by Disease (in Billion U.S. Dollars)*." Statista, Statista Inc., 28 Jun 2013, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health, Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/ (last visited January 26, 2022)
